Literature DB >> 8836051

The surgical treatment and outcome of pathological fractures in localised osteosarcoma.

A Abudu1, N K Sferopoulos, R M Tillman, S R Carter, R J Grimer.   

Abstract

We reviewed the surgical treatment and oncological results of 40 patients with pathological fractures from localised osteosarcoma of the long bones to determine the outcome of limb salvage in their management. All had had adjuvant chemotherapy. There were 26 males and 14 females with a median age at diagnosis of 18 years (2 to 46) and a median follow-up of 55 months (8 to 175). We performed limb salvage in 27 patients and amputation in 13. The margins of resection were radical in five patients, wide in 26, marginal in six, wide but contaminated in two and intralesional in one. Local recurrence developed in 19% of those treated by limb salvage and in none of those who had an amputation. The cumulative five-year survival of all the patients was 57% and in those treated by limb salvage or amputation it was 64% and 47%, respectively (p > 0.05). Limb-sparing surgery with adequate margins of excision can be achieved in many patients with pathological fractures from primary osteosarcoma without compromising survival, but the risk of local recurrence is significant.

Entities:  

Mesh:

Year:  1996        PMID: 8836051

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  24 in total

1.  Limb Salvage Versus Amputation in Conventional Appendicular Osteosarcoma: a Systematic Review.

Authors:  Julio J Jauregui; Vidushan Nadarajah; Joseph Munn; Robert Pivec; Bhaveen H Kapadia; Daniel M Lerman; Aditya V Maheshwari
Journal:  Indian J Surg Oncol       Date:  2018-01-20

2.  Pathologic fracture in childhood and adolescent osteosarcoma: A single-institution experience.

Authors:  Lindsay Haynes; Sue C Kaste; Kirsten K Ness; Jianrong Wu; Lucia Ortega-Laureano; Michael Bishop; Michael Neel; Bhaskar Rao; Israel Fernandez-Pineda
Journal:  Pediatr Blood Cancer       Date:  2016-11-05       Impact factor: 3.167

3.  Femoral fracture acting as an "ominous masquerade" in a 7-year-old child.

Authors:  Amit Srivastava; Aditya N Aggarwal; Puneet Mishra; Dheeraj Bhateja
Journal:  J Clin Orthop Trauma       Date:  2016-10-17

4.  Two case-reports of the limb salvage treatment of osteosarcoma consolidated with obvious pathological fractures.

Authors:  Q Cui; D F Li; C Liu; J Guo; S B Liu; Y S Liu; J M Zhai; Yanjun Zeng
Journal:  Pathol Oncol Res       Date:  2011-01-09       Impact factor: 3.201

5.  Management and prognostic significance of pathological fractures through chondrosarcoma of the femur.

Authors:  Jose I Albergo; Czar L Gaston; Lee M Jeys; Arun Khajuria; Simon R Carter; Roger M Tillman; Adesegun T Abudu; Robert J Grimer
Journal:  Int Orthop       Date:  2015-02-25       Impact factor: 3.075

6.  Challenges in management of benign bone tumours complicated by pathological fracture in paediatric population.

Authors:  Yasir Salam Siddiqui; Mazhar Abbas; Julfiqar Muhammad; Mohd Khalid A Sherwani; Mohammad Jesan Khan; Akash Yadav
Journal:  Int J Burns Trauma       Date:  2021-06-15

7.  The impact of pathological fractures on therapy outcome in patients with primary malignant bone tumours.

Authors:  Babak Moradi; Anita Zahlten-Hinguranage; Burkhard Lehner; Felix Zeifang
Journal:  Int Orthop       Date:  2009-12-13       Impact factor: 3.075

Review 8.  A review of clinical and molecular prognostic factors in osteosarcoma.

Authors:  Jonathan C M Clark; Crispin R Dass; Peter F M Choong
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-27       Impact factor: 4.553

9.  Complications and risk factors for failure of rotationplasty: review of 25 patients.

Authors:  Chigusa Sawamura; Francis J Hornicek; Mark C Gebhardt
Journal:  Clin Orthop Relat Res       Date:  2008-04-11       Impact factor: 4.176

10.  Effect of pathological fracture on limb salvage surgery with preservation of the epiphysis in children with osteosarcoma of the distal femur: Two case reports.

Authors:  Kai Zheng; Xiuchun Yu; Zhengqi Chang; Songfeng Xu; Ming Xu
Journal:  Mol Clin Oncol       Date:  2016-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.